A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07518186 · RECRUITING
Trial details
- NCT number
- NCT07518186
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2029-04-29
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.